Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer

التفاصيل البيبلوغرافية
العنوان: Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer
المؤلفون: Timothy Tree, Bernard V. North, Sophie Papa, K. Owczarczyk, Sultan Abdul-Jawad, Hartmut Kristeleit, Kamila Sychowska, Piers E.M. Patten, Sheeba Irshad, Clara Domingo-Vila, Catherine Tremain, Jennifer Vidler, Paul Fields, Thomas Lechmere, Emily Pollock, Rosalind Graham, Carl Graham, Jeffrey Seow, Leticia Monin, Thanussuyah Alaguthurai, Miguel Muñoz-Ruiz, Michael H. Malim, Jack Cooper, Katie J. Doores, Charalampos Gousis, Adrian Hayday, Duncan R. McKenzie, Angela Swampillai
المصدر: Cancer Cell
بيانات النشر: Published by Elsevier Inc., 2021.
سنة النشر: 2021
مصطلحات موضوعية: Cancer Research, 2019-20 coronavirus outbreak, Cellular immunity, COVID-19 Vaccines, Time Factors, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), T-Lymphocytes, Antibodies, Viral, Article, Immunogenicity, Vaccine, Neoplasms, medicine, Humans, In patient, BNT162 Vaccine, Immunization Schedule, Messenger RNA, Immunity, Cellular, business.industry, SARS-CoV-2, Vaccination, Case-control study, Cancer, COVID-19, medicine.disease, Virology, Immunity, Humoral, Treatment Outcome, Oncology, Case-Control Studies, Immunoglobulin G, Host-Pathogen Interactions, Spike Glycoprotein, Coronavirus, Cytokines, business
اللغة: English
تدمد: 1878-3686
1535-6108
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92f3f08b823ccf3eed45ea9d826b9afd
http://europepmc.org/articles/PMC8506107
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....92f3f08b823ccf3eed45ea9d826b9afd
قاعدة البيانات: OpenAIRE